FREE NEJM E-TOC    HOME   |   SUBSCRIBE   |   CURRENT ISSUE   |   PAST ISSUES   |   COLLECTIONS   |   Search Term  Advanced Search

Sign in | Get NEJM's E-Mail Table of Contents — Free | Subscribe

Previous Volume 322:1028-1031 April 12, 1990 Number 15 Next

	Add to Personal Archive Add to Citation Manager Notify a Friend E-mail When Cited PubMed Citation

Abstract

Erythromycin mimics the effect of the gastrointestinal polypeptide motilin on gastrointestinal motility, probably by binding to motilin receptors and acting as a motilin agonist. Erythromycin may thus have clinical application in patients with disturbances of gastroduodenal motility, such as diabetic gastroparesis. To examine this possibility, we studied the effect of erythromycin on gastric emptying in 10 patients with insulin-dependent diabetes mellitus and gastroparesis. We studied the emptying of liquids and solids simultaneously on separate days after the intravenous administration of erythromycin (200 mg) or placebo, using a double-isotope technique and a double-blind, crossover design. Erythromycin shortened the prolonged gastric-emptying times for both liquids and solids to normal. For example, 120 minutes after the ingestion of a solid meal, mean (+/- SE) retention was 63 +/- 9 percent with placebo and 4 +/- 1 percent with erythromycin, as compared with 9 +/- 3 percent in 10 healthy subjects. The corresponding values 120 minutes after the ingestion of a liquid meal were 32 +/- 4, 9 +/- 3, and 4 +/- 1 percent, respectively. Gastric emptying also improved, but to a lesser degree, in the 10 patients after four weeks of treatment with oral erythromycin (250 mg three times a day). These preliminary results suggest that erythromycin may have therapeutic value in patients with severe diabetic gastroparesis.

Source Information

Department of Internal Medicine, University Hospital Gasthuisberg, University of Leuven, Belgium.

This article has been cited by other articles:

• Song, G.-Q., Chen, J. D. Z. (2007). Synchronized gastric electrical stimulation improves delayed gastric emptying in nonobese mice with diabetic gastroparesis. J. Appl. Physiol. 103: 1560-1564 [Abstract] [Full Text]  
• Abrahamsson, H. (2007). Treatment options for patients with severe gastroparesis. Gut 56: 877-883 [Full Text]  
• Hawkyard, C. V., Koerner, R. J. (2007). The use of erythromycin as a gastrointestinal prokinetic agent in adult critical care: benefits versus risks. J Antimicrob Chemother 59: 347-358 [Abstract] [Full Text]  
• Camilleri, M. (2007). Diabetic Gastroparesis. NEJM 356: 820-829 [Full Text]  
• Bouvet, L., Duflo, F., Bleyzac, N., Mion, F., Boselli, E., Allaouchiche, B., Chassard, D. (2006). Erythromycin promotes gastric emptying during acute pain in volunteers.. Anesth. Analg. 102: 1803-1808 [Abstract] [Full Text]  
• Matsuura, B., Dong, M., Naik, S., Miller, L. J., Onji, M. (2006). Differential Contributions of Motilin Receptor Extracellular Domains for Peptide and Non-peptidyl Agonist Binding and Activity. J. Biol. Chem. 281: 12390-12396 [Abstract] [Full Text]  
• Abell, T. L., Malinowski, S., Minocha, A. (2006). Nutrition Aspects of Gastroparesis and Therapies for Drug-Refractory Patients. Nutr Clin Pract 21: 23-33 [Abstract] [Full Text]  
• Magnuson, B. L., Clifford, T. M., Hoskins, L. A., Bernard, A. C. (2005). Enteral Nutrition and Drug Administration, Interactions, and Complications. Nutr Clin Pract 20: 618-624 [Abstract] [Full Text]  
• Meier, J. J., Kemmeries, G., Holst, J. J., Nauck, M. A. (2005). Erythromycin Antagonizes the Deceleration of Gastric Emptying by Glucagon-Like Peptide 1 and Unmasks Its Insulinotropic Effect in Healthy Subjects. Diabetes 54: 2212-2218 [Abstract] [Full Text]  
• Patole, S, Rao, S, Doherty, D (2005). Erythromycin as a prokinetic agent in preterm neonates: a systematic review. Arch. Dis. Child. Fetal Neonatal Ed. 90: F301-f306 [Abstract] [Full Text]  
• Matsuura, B., Dong, M., Coulie, B., Pinon, D. I., Miller, L. J. (2005). Demonstration of a Specific Site of Covalent Labeling of the Human Motilin Receptor Using a Biologically Active Photolabile Motilin Analog. J. Pharmacol. Exp. Ther. 313: 1101-1108 [Abstract] [Full Text]  
• Thielemans, L., Depoortere, I., Perret, J., Robberecht, P., Liu, Y., Thijs, T., Carreras, C., Burgeon, E., Peeters, T. L. (2005). Desensitization of the Human Motilin Receptor by Motilides. J. Pharmacol. Exp. Ther. 313: 1397-1405 [Abstract] [Full Text]  
• Blase, E., Taylor, K., Gao, H.-y., Wintle, M., Fineman, M. (2005). Pharmacokinetics of an Oral Drug (Acetaminophen) Administered at Various Times in Relation to Subcutaneous Injection of Exenatide (Exendin-4) in Healthy Subjects. J Clin Pharmacol 45: 570-577 [Abstract] [Full Text]  
• INUI, A., ASAKAWA, A., BOWERS, C. Y., MANTOVANI, G., LAVIANO, A., MEGUID, M. M., FUJIMIYA, M. (2004). Ghrelin, appetite, and gastric motility: the emerging role of the stomach as an endocrine organ. FASEB J. 18: 439-456 [Abstract] [Full Text]  
• Levy, H., Hayes, J., Boivin, M., Tomba, T. (2004). Transpyloric Feeding Tube Placement in Critically Ill Patients Using Electromyogram and Erythromycin Infusion. Chest 125: 587-591 [Abstract] [Full Text]  
• Tack, J, Caenepeel, P, Piessevaux, H, Cuomo, R, Janssens, J (2003). Assessment of meal induced gastric accommodation by a satiety drinking test in health and in severe functional dyspepsia. Gut 52: 1271-1277 [Abstract] [Full Text]  
• Lemahieu, W. P. D., Maes, B. D., Ghoos, Y., Rutgeerts, P., Verbeke, K., Vanrenterghem, Y. (2003). Measurement of hepatic and intestinal CYP3A4 and PGP activity by combined po + iv [14C]erythromycin breath and urine test. Am. J. Physiol. Gastrointest. Liver Physiol. 285: G470-G482 [Abstract] [Full Text]  
• Lata, P. F, Pigarelli, D. L W. (2003). Chronic Metoclopramide Therapy for Diabetic Gastroparesis. The Annals of Pharmacotherapy 37: 122-126 [Abstract] [Full Text]  
• Camilleri, M, Talley, N J, Verlinden, M (2002). Motilin agonists and dyspepsia: throwing out the baby with the bath water. Gut 51: 612-613 [Full Text]  
• Van Vlem, B., Schoonjans, R., Vanholder, R., Vos, M. D., Depoortere, I., Peeters, T. L., Lefebvre, R. (2002). In vitro evaluation of motilin agonism by macrolide immunosuppressive drugs. Nephrol Dial Transplant 17: 973-977 [Abstract] [Full Text]  
• Saremi, F., Jadvar, H., Siegel, M. E. (2002). Pharmacologic Interventions in Nuclear Radiology: Indications, Imaging Protocols, and Clinical Results. RadioGraphics 22: 477-490 [Abstract] [Full Text]  
• Faas, H., Hebbard, G. S., Feinle, C., Kunz, P., Brasseur, J. G., Indireshkumar, K., Dent, J., Boesiger, P., Thumshirn, M., Fried, M., Schwizer, W. (2001). Pressure-geometry relationship in the antroduodenal region in humans. Am. J. Physiol. Gastrointest. Liver Physiol. 281: G1214-G1220 [Abstract] [Full Text]  
• TACK, J, PEETERS, T (2001). What comes after macrolides and other motilin stimulants?. Gut 49: 317-318 [Full Text]  
• Jones, K. L., Russo, A., Stevens, J. E., Wishart, J. M., Berry, M. K., Horowitz, M. (2001). Predictors of Delayed Gastric Emptying in Diabetes. Diabetes Care 24: 1264-1269 [Abstract] [Full Text]  
• Ng, P C, So, K W, Fung, K S C, Lee, C H, Fok, T F, Wong, E, Wong, W, Cheung, K L, Cheng, A F B (2001). Randomised controlled study of oral erythromycin for treatment of gastrointestinal dysmotility in preterm infants. Arch. Dis. Child. Fetal Neonatal Ed. 84: 177F-182 [Abstract] [Full Text]  
• Ueno, N., Inui, A., Asakawa, A., Takao, F., Ichibangase, A., Komatsu, Y., Kasuga, M. (2001). Erythromycin Administration Before Sleep is Effective in Decreasing Fasting Hyperglycemia in Type 2 Diabetic Patients. Diabetes Care 24: 607-607 [Full Text]  
• Asai, T., Murao, K., Shingu, K. (2000). Pre-operative oral erythromycin reduces residual gastric volume and acidity. Br J Anaesth 85: 861-864 [Abstract] [Full Text]  
• Kamm, M A (2000). Why the enteric nervous system is important to clinicians. Gut 47: iv8-9 [Full Text]  
• Cowles, V. E., Nellans, H. N., Seifert, T. R., Besecke, L. M., Segreti, J. A., Mohning, K. M., Faghih, R., Verlinden, M. H., Wegner, C. D. (2000). Effect of Novel Motilide ABT-229 versus Erythromycin and Cisapride on Gastric Emptying in Dogs. J. Pharmacol. Exp. Ther. 293: 1106-1111 [Abstract] [Full Text]  
• Miller, P., Roy, A., St-Pierre, S., Dagenais, M., Lapointe, R., Poitras, P. (2000). Motilin receptors in the human antrum. Am. J. Physiol. Gastrointest. Liver Physiol. 278: G18-G23 [Abstract] [Full Text]  
• De Winter, B Y, Boeckxstaens, G E, De Man, J G, Moreels, T G, Schuurkes, J A J, Peeters, T L, Herman, A G, Pelckmans, P A (1999). Effect of different prokinetic agents and a novel enterokinetic agent on postoperative ileus in rats. Gut 45: 713-718 [Abstract] [Full Text]  
• Tanaka, T., Mizumoto, A., Mochiki, E., Suzuki, H., Itoh, Z., Omura, S. (1998). Effects of EM574 and Cisapride on Gastric Contractile and Emptying Activity in Normal and Drug-Induced Gastroparesis in Dogs. J. Pharmacol. Exp. Ther. 287: 712-719 [Abstract] [Full Text]  
• Thomsen, M. S., Groes, L., Agerso, H., Kruse, T. (1998). Lack of Pharmacokinetic Interaction between Tiagabine and Erythromycin. J Clin Pharmacol 38: 1051-1056 [Abstract]  
• Coulie, B, Tack, J, Peeters, T, Janssens, J (1998). Involvement of two different pathways in the motor effects of erythromycin on the gastric antrum in humans. Gut 43: 395-400 [Abstract] [Full Text]  
• Petrakis, J., Vassilakis, J. S., Karkavitsas, N., Tzovaras, G., Epanomeritakis, E., Tsiaoussis, J., Xynos, E. (1998). Enhancement of Gastric Emptying of Solids by Erythromycin in Patients With Roux-en-Y Gastrojejunostomy. Arch Surg 133: 709-714 [Abstract] [Full Text]  
• Choi, M.-G., Camilleri, M., Burton, D. D., Johnson, S., Edmonds, A. (1998). Dose-Related Effects of N-Demethyl-N-Isopropyl-8,9-anhydroerythromycin A 6,9-hemiacetal on Gastric Emptying of Solids in Healthy Human Volunteers. J. Pharmacol. Exp. Ther. 285: 37-40 [Abstract] [Full Text]  
• Burt, M., Scott, A., Williard, W. C., Pommier, R., Yeh, S., Bains, M. S., Turnbull, A. D., Fortner, J. G., McCormack, P. M., Ginsberg, R. J. (1996). ERYTHROMYCIN STIMULATES GASTRIC EMPTYING AFTER ESOPHAGECTOMY WITH GASTRIC REPLACEMENT: A RANDOMIZED CLINICAL TRIAL. J. Thorac. Cardiovasc. Surg. 111: 649-654 [Abstract] [Full Text]  
• Clark, C. M., Lee, D. A. (1995). Prevention and Treatment of the Complications of Diabetes Mellitus. NEJM 332: 1210-1217 [Full Text]  
• Llewelyn, J G (1995). Conservative treatment with alternative routes of drug administration. BMJ 310: 311-311 [Full Text]  
• Nathan, D. M. (1993). Long-Term Complications of Diabetes Mellitus. NEJM 328: 1676-1685 [Full Text]  
• Coulie, B., Matsuura, B., Dong, M., Hadac, E. M., Pinon, D. I., Feighner, S. D., Howard, A. D., Miller, L. J. (2001). Identification of Peptide Ligand-binding Domains within the Human Motilin Receptor Using Photoaffinity Labeling. J. Biol. Chem. 276: 35518-35522 [Abstract] [Full Text]